Quantitative evaluation of ischemic myocardial scar tissue by unenhanced T1 mapping using 3.0 tesla MR scanner

Diagnostic and Interventional Radiology

Volumn 20, Issue 5, 2014, Pages 407-413

  Okur, Aylin ^a,b   Kantarci, Mecit ^b   Kizrak, Yeşim ^b   Yildiz, Sema ^c   Pirimoǧlu, Berhan ^b   Karaca, Leyla ^b   Oǧul, Hayri ^b   Sevimli, Serdar ^b  

^a BOZOK UNIVERSITY   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

^c HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADULT; ARTICLE; CARDIAC IMAGING; CARDIAC MAPPING SYSTEM; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GOLD STANDARD; HEART INFARCTION; HEART MUSCLE INJURY; HUMAN; IMAGE QUALITY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PROSPECTIVE STUDY; RELAXATION TIME; SCAR; SENSITIVITY AND SPECIFICITY; T1 MAPPING; T2 WEIGHTED IMAGING; CICATRIX; COMPLICATION; EVALUATION STUDY; FEASIBILITY STUDY; HEART MUSCLE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; REPRODUCIBILITY;

CICATRIX; EVALUATION STUDIES AS TOPIC; FEASIBILITY STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84906777103     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: 10.5152/dir.2014.13520     Document Type: Article

References (28)

1. Gersh BJ, Anderson JL. Thrombolysis and myocardial salvage: results of clinical trials and the animal paradigm. Circulation 1993; 88:296-306.
2. Vogel-Claussen J, Rochitte CE, Wu KC, et al. Delayed enhancement MR imaging: utility in myocardial assessment. Radio-graphics 2006; 26:795-810.
3. Kim RJ, Wu E, Rafael A, Chen EL, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343:1445-1453.
4. Messroghli DR, Walters K, Plein S, et al. Myocardial T1 mapping: application to patients with acute and chronic myocar-dial infarction. Magn Reson Med 2007; 58:34-40.
5. Belloni E, Marchesi G, Aschieri D, et al. Inversion time prolongation at late enhancement cardiac MRI in a myeloma patient. Diagn Interv Radiol 2012; 18:552-554.
6. Ozbek O, Acar K, Kayrak M, et al. Relationship between color M-mode echocar-diography flow propagation and cardiac iron load on MRI in patients with thal-assemia major. Diagn Interv Radiol 2012; 18:208-214.
7. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011; 57:891-903.
8. Lim RP, Hecht EM, Xu J, et al. 3D non-gadolinium-enhanced ECG-gated MRA of the distal lower extremities: preliminary clinical experience. J Magn Reson Imaging 2008; 28:181-189.
9. Edelman RR, Sheehan JJ, Dunkle E, Schin-dler N, Carr J, Koktzoglou I. Quiescent-interval single-shot unenhanced magnetic resonance angiography of peripheral vascular disease: technical considerations and clinical feasibility. Magn Reson Med 2010; 63:951-958.
10. Dall'Armellina E, Ferreira VM, Kharbanda RK, et al. Diagnostic value of pre-contrast T1 mapping in acute and chronic myocar-dial infarction. JACC Cardiovasc Imaging 2013; 6:739-742.
11. Kaldoudi E, Williams CR. Relaxation time measurements in NMR imaging. I. Longitudinal relaxation time. Concepts Magn Reson 1993; 5:217-242.
12. Messroghli DR, Niendorf T, Schulz-Menger J, Dietz R, Friedrich MG. T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson 2003; 5:353-359.
13. Lee JJ, Liu S, Nacif MS, et al. Myocardi-al T1 and extracellular volume fraction mapping at 3 Tesla. J Cardiovasc Magn Reson 2011; 13:75.
14. Rajappan K, Bellenger NG, Anderson L, Pennell DJ. The role of cardiovascular magnetic resonance in heart failure. Eur J Heart Fail 2000; 2:241-252.
15. Lima JAC, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI: potential mechanisms. Circulation 1995, 92:1117-1125.
16. Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004; 109:2411-2416.
17. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001; 104:1101-1107.
18. Wu E, Judd RM, Vargas JD, et al. Visualisation of presence, location, and transmu-ral extent of healed Q- wave and non-Q-wave myocardial infarction. Lancet 2001; 357:21-28.
19. Mahrholdt H, Wagner A, Holly TA, et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 2002; 106:2322-2327.
20. Dall'Armellina E, Karia N, Lindsay AC, et al. Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index. Circ Cardiovasc Imaging 2011; 4:228-236.
21. Engblom H, Hedström E, Heiberg E, Wagner GS, Pahlm O, Arheden H. Rapid initial reduction of hyperenhanced myocardium after reperfused first myocardial infarction suggests recovery of the periin-farction zone: one year follow up by MRI. Circ cardiovasc imaging 2009; 2:47-55.
22. Ibrahim T, Makowski MR, Jankauskas A, et al. Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction. JACC Car-diovasc imaging 2009; 2:580-588.
23. McNamara MT, Higgins CB. Magnetic resonance imaging of chronic myocardi-al infarcts in man. AJR Am J Roentgenol 1986; 146:315-320.
24. Higgins DM, Ridgway JP, Radjenovic A, Sivananthan UM, Smith MA. T1 measurement using a short acquisition period for quantitative cardiac applications. Med Phys 2005; 32:1738-1746.
25. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004; 52:141-146.
26. Messroghli DR, Plein S, Higgins DM, et al. Human myocardium: single-breath-hold MR T1 mapping with high spatial reso-lution-reproducibility study. Radiology 2006; 238:1004-1012.
27. Bottomley PA, Foster TH, Argersinger RE, Pfeifer LM. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age. Med Phys 1984; 11:425-448.
28. Rudolph A, Abdel-Aty H, Bohl S, et al. Noninvasive detection of fibrosis applying contrastenhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 2009; 53:284-291.